“We are excited about our partnership with Invibio® to continue meeting our goal of developing innovative products that provide improved outcomes for our patients and medical professionals." said Ashesh Shah, CEO, Maxx Medical.
Plymouth Meeting, PA (PRWEB) February 24, 2016
Maxx Orthopedics, Inc. the U.S. subsidiary of Maxx Medical, Pvt. Ltd., a rapidly expanding global orthopedics device company, today announced that it has partnered with Invibio Knees Ltd (“Invibio®”) to develop a PEEK- OPTIMA® femoral knee replacement.
The femoral knee replacement is in pre-market phase and was created using advanced technology to address some of the unmet needs of more than half a million patients annually who are not satisfied with their outcome after total knee arthroplasty using metal-based knee solutions.
“We are excited about our partnership with Invibio® to continue meeting our goal of developing innovative products that provide improved outcomes for our patients and medical professionals. It is amazing to see and feel the difference with the PEEK-OPTIMA® material. The products resulting from this collaboration are a true testament to our passion for patients,” said Ashesh Shah, CEO, Maxx Medical.
The knee will be on display at the 2016 Annual Association of Orthopedic Surgeons Meeting, March 3 through March 5, 2016 inside Maxx Booth #3715 and Invibio® Booth #3331. The companies have undertaken extensive lab testing and are now planning international clinical trials to further evaluate and test this innovative product.
Maxx Orthopedics designs, develops, and supplies joint replacement products such as its flagship product, the Freedom Total Knee® System, which recently completed over 25,000 successful implantations worldwide.
Invibio® pioneers PEEK-OPTIMA®-based medical device solutions that are currently being used in more than five million implanted devices worldwide. Their biocompatible PEEK- OPTIMA® polymers are widely recognized and frequently used within the spinal fusion market.